Cardon Lon 4
4 · Mirum Pharmaceuticals, Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Cardon Lon
Director
Transactions
- Award
Stock Option (right to buy)
2022-12-19+34,000→ 34,000 totalExercise: $18.00Exp: 2032-12-18→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant (December 19, 2022).